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A B S T R A C T
Background. Low birthweight (LBW) has been shown to in-
crease the risk of severe kidney disease. Studies have also shown
associations between LBW and lower estimated glomerular fil-
tration rate (GFR) in young adults. In this study we investigated
whether LBW associates with measured GFR (mGFR) in
middle-aged mainly healthy adults.
Methods. We invited individuals with LBW (1100–2300 g) and
individuals with normal BW (NBW; 3500–4000 g) ages 41–
52 years. GFR was measured using plasma clearance of iohexol.
BW and BW for gestational age (BWGA) were obtained from
the Medical Birth Registry of Norway and tested as main pre-
dictors. GFR was the main outcome.
Results. We included 105 individuals (57 LBW and 48 NBW).
The mean GFR was 95 6 14 mL/min/1.73 m2 in the LBW group
and 100 6 13 mL/min/1.73 m2 in the NBW group (P¼ 0.04).
There was a significant sex difference: in women the mean GFR
was 90 6 12 versus 101 6 14 mL/min/1.73 m2 in the LBW and
NBW groups, respectively (P¼ 0.006), whereas corresponding
values for men were 101 6 15 versus 100 6 11 mL/min/1.73 m2
(P¼ 0.7). Using linear regression, we found the GFR was
4.5 mL/min/1.73 m2 higher per 1 kg higher BW for women
(P¼ 0.02), with a non-significant 1.2 mL/min/1.73 m2 lower
GFR for men (P¼ 0.6). In analyses of BWGA, there was also a
significant association for women, but not for men.
Conclusions. Middle-aged mainly healthy women with LBW
had lower mGFR as compared with women with NBW. No
such difference was found for men.
Keywords: chronic kidney disease, iohexol clearance, low
birthweight, measured GFR
I N T R O D U C T I O N
Previous studies have shown that low birthweight (LBW)
associates with a reduced number of nephrons [1, 2]. This
impaired nephron endowment is thought to link BW to
an increased risk of kidney disease [3–5]. Supportive of
this are several studies showing an increased risk of
albuminuria [6–8], reduced kidney function [9–11] and
end-stage renal disease [9, 12, 13] for persons with LBW
compared with normal BW (NBW), with an overall 1.7
times increase in the risk of kidney-related outcomes [14].
Although the exact mechanism behind this association is
unknown, it is believed that the low number of nephrons
causes compensatory nephron hypertrophy and hyperfiltra-
tion [3]. This, however, comes at a cost of increased strain
on the remaining nephrons, leading to increased nephro-
sclerosis and a further reduction in functional nephron
mass [15]. The result is a reduction in glomerular filtra-
tion rate (GFR).
In most studies, both in paediatric and adult populations,
the GFR is estimated using creatinine-based formulas [16,
17]. This is prone to error, with differences in body compo-
sition between individuals with LBW and NBW. We have
found only one study using clearance of an external marker
[18] and one using urinary creatinine clearance [19]. The
use of recollection for BW data [10], inclusion of only
patients with a registered BW and exclusion of patients (es-
pecially women) who have changed names since birth [9]
are other weaknesses of previous studies. In some studies
there appears to be a sex difference in the impact of BW on
kidney-related outcomes [10, 17]. It is uncertain whether
this reflects real differences in the mechanism and effect size
of nephron endowment on kidney function or is reflecting
errors in creatinine-based GFR estimation.
In this study we aimed to investigate differences in mea-
sured GFR (mGFR) in mainly healthy adults ages 40–
50 years. We tested BW and BW for gestational age
(BWGA) as the main predictors. We also aimed to study
possible sex differences.
VC The Author(s) 2020. Published by Oxford University Press on behalf of ERA-EDTA.
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M A T E R I A L S A N D M E T H O D S
Registries
Since 1967, the Medical Birth Registry of Norway (MBRN)
has registered data on all births in Norway [20]. This compul-
sory notification includes information about the mother’s
health before and during pregnancy, as well as data concerning
the delivery and the newborn child’s health.
Study population
This is a retrospective longitudinal cohort study using BW
from the MBRN as the main inclusion source. The MBRN se-
lected 200 participants with LBW and 200 participants with
NBW currently residing in one of the five municipalities in the
Haugesund area on the west coast of Norway (Haugesund,
Karmøy, Bokn, Tysvær and Sveio). The LBW group had a BW
of 1100–2300 g and the NBW group had a BW of 3500–4000 g.
Participants in both groups were born between 1967 and 1976
and only participants who were the result of a singleton birth
were included. Invitations were sent out between May 2018 and
April 2019. All non-responders were sent a follow-up letter af-
ter 1 month, except for the last inclusion group of 60 persons,
as enough participants were included. Based on power calcula-
tions f90% power, estimated effect size for GFR of 85 versus
95 mL/min/1.73 m2 [standard deviation (SD) 15] and 5% signif-
icance level [8, 14, 17]g, we estimated a need for 48 participants
in each group.
Exclusion criteria were diabetes mellitus [defined as either
using antidiabetic medications or glycated haemoglobin
(HbA1c)>53 mmol/mol (7%)], estimated GFR (eGFR)
<50 mL/min/1.73 m2 (using the Chronic Kidney Disease
Epidemiology Collaboration equation [21]), use of
antihypertensive medications, regular use of non-steroidal anti-
inflammatory drugs (NSAIDs) , cancer (either onset <5 years
ago or treated with chemotherapy), allergy to computed tomog-
raphy contrast agent or known multiple allergies.
Measurements at participation
Participant height was measured and rounded to the nearest
centimetre. body weight was measured in kilograms using the
same instrument for all participants and one decimal was
recorded. Blood pressure was measured seated, once before in-
jection of iohexol and twice during the 30 min following injec-
tion. The mean of the last two measurements was used for
analysis.
GFR was measured after injection of 5 mL of iohexol
(Omnipaque300 mgI/mL, GE Healthcare, Oslo, Norway) via an
indwelling intravenous catheter in the antecubital vein of the
dominant arm, followed by flushing with 10 mL of normal sa-
line. The syringe and packaging were weighed before and after
injection to a precision of 0.01 g. Blood samples were drawn
from the opposite arm 2 and 4 h after the injection of iohexol.
Analysis of iohexol concentration was done at Haukeland
University Hospital. Calculation of GFR was done using the
Jødal–Brøchner-Mortensen formula [22].
Urine albumin:creatinine ratio was measured in the first
void urine on 3 consecutive days. The median of all three was
used for analysis. Microalbuminuria was defined as a median
urine albumin:creatinine ratio3 mg/mmol.
Exposure variables
The MBRN provided BW, GA and a z-score of the BWGA
by sex (z-score values given as units of SDs from the mean). For
use in the analyses, small for GA (SGA) was defined as a z-score
KEY LEARNING POINTS
What is already known about this subject?
1. Low birthweight (BW) increases the risk of albuminuria, chronic kidney disease and end-stage renal disease.
2. Limited data suggest that there is a sex difference in this association.
3. Except for one twin study and another study after kidney donation, all studies on kidney function in relation to BW have
used estimated kidney function rather than measured glomerular filtration rate (mGFR).
What this study adds?
1. This is the first low BW study analysing differences in mGFR in mainly healthy middle-aged adults.
2. Women with low BW had lower mGFR than women with normal BW; there was no difference in men.
3. Both BW and BW for gestational age (GA) is of importance, while GA or preterm versus term seems of less importance.
What impact may this have on practice and policy?
1. This will further acknowledge low BW as a risk factor for kidney disease in adults, even in otherwise healthy middle-
aged women.
2. This can guide future research on BW and kidney function, demonstrating the need for using mGFR rather than esti-
mated GFR.
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below the 10th percentile, i.e.<1.28. Maternal age, civil status
and information on maternal pre-eclampsia were also obtained
from the MBRN. Preterm birth was defined as birth before the
37th week of gestation. Self-reported civil status (living alone or
living with spouse/partner), education level (completed higher
education or not), household income (above or below 800 000
Norwegian krones (NOK; equivalent to 73 700 euros on 11
March 2020), exercise frequency, smoking status and alcohol
consumption were obtained from a questionnaire at
examination.
Statistical analyses
All statistics were determined using R version 3.6.0 (R
Foundation for Statistical Computing, Vienna, Austria) [23].
Descriptive methods were used to characterize. Intergroup dif-
ferences (LBW versus NBW) were tested using independent t-
tests for continuous data and chi-squared tests for categorical
data, except for maternal pre-eclampsia and maternal civil sta-
tus, which were analysed with Barnard’s unconditional exact
test for binomial models [24]. The sex-stratified mean mGFR
and 95% confidence interval (CI) was estimated using four dif-
ferent dichotome variables (BW group, z-score of BWGA, pre-
term birth and maternal pre-eclampsia). The same variables
were fitted together with sex and interaction between sex and
the main variable in a linear regression model using mGFR as
the dependent variable. From this model, the P-value of the sex
interaction was reported. We also fitted a sex-stratified multi-
variate regression model using mGFR as a dependent variable.
In this model the independent variables (BW group, BW/kg, z-
score of BWGA/1 unit, GA and maternal pre-eclampsia) were
tested both unadjusted and adjusted for age at examination,
maternal age and maternal civil status. The same modelling was
used for a logistic regression model using mGFR<90 mL/min/
1.73 m2 as the dependent variable. A significance level of 0.05
was chosen for all tests.
Ethics
Ethical approval was given by the regional ethics committee
(REK2017/927). All participants signed an informed consent
formula at inclusion in the study. This study adheres to the
Declaration of Helsinki.
R E S U L T S
Among the 400 people invited, 176 (44%) responded (96 LBW
and 80 NBW); 29 did not want to participate and 40 individuals
were excluded due to antihypertensive treatment, diabetes, use
of various medications or other causes. Two other participants
were excluded after Day 1, one due to newly diagnosed diabetes
and the other due to possible allergic reaction to iohexol.
Details are shown in Figure 1. No information was available for
the non-responders and excluded participants. A total of 105
participants (57 LBW and 48 NBW; 45% male) were thus in-
cluded in the analysis. The group with LBW had a median BW
of 2000 g (range 1160–2300) and the NBW group had a median
BW of 3735 g (range 3520–3980). Preterm birth was recorded
in 68% of the LBW group and none in the NBW group. At ex-
amination, there was no significant difference in weight, body
mass index (BMI) or body surface area; however, participants
with the LBW group seemed to be shorter, with a mean height
of 169.7 versus 173.2 cm. This difference was statistically signifi-
cant for women (mean difference 2.9 cm; P¼ 0.04) but not for
men (mean difference 1.8 cm; P¼ 0.3). Blood pressure was
higher in the LBW group. The median urine albumin:creatinine
ratio was 0.4 mg/mmol for both LBW and NBW. Only one par-
ticipant (male LBW) had a median albumin:creatinine ratio
>3 mg/mmol. Three of 54 women that had been pregnant
reported pre-eclampsia in their obstetric history (2 LBW and 1
NBW). Table 1 shows detailed characteristics of the two BW
groups. Differences in characteristics between male and female
participants are shown in Supplementary data, Table S1.
The mean mGFR of participants with LBW was
95 6 14 mL/min/1.73 m2, compared with 100 6 13 mL/min/
1.73 m2 in participants with NBW (P¼ 0.04). In contrast, the
eGFR was not different between the BW groups (P¼ 0.8; see
Table 1 and Supplementary data, Table S1). Comparing the
mGFR of participants born SGA compared with appropriate
for GA and for participants born preterm versus full term
yielded non-significant differences. When analysing men and
women separately we found the associations between mGFR











29 did not want to participate
• 11 LBW, 18 NBW
Excluded:
• Hypertension (n=14)
  - 10 LBW, 4 NBW
  - 10 female, 4 male
• Medication (n=8)
  - 4 LBW, 4 NBW
• Diabetes mellitus (n=3)
• Cancer (n=2)
• Other causes (n=13)
  - 10 LBW, 3 NBW
Excluded:
• Newly diagnosed
  diabetes mellitus (n=1)
• Allergic reaction iohexol (n=1)
FIGURE 1: Inclusion process. LBW, BW2300 g); NBW, BW
3500–4000 g.
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Table 1. Characteristics of participants at birth and examination
Characteristics LBW n¼ 57 NBW n¼ 48 P-value
At birth
Male participantsa 23 (40) 24 (50) 0.4
BW (g)b 2000 (1160–2300) 3740 (3520–3980) –
BWGA (SDc)b 1.2 (4.7–1.8) 0.2 (0.4–1.5) <0.001
Prematurea 39 (70) 0 (0) <0.001
GAd 34.5 6 3.4 40.3 6 1.4 <0.001
Maternal pre-eclampsiae 8 (14) 1 (2) 0.04
Birth length (cm)b 44 (37–49) 51 (48–54) <0.001
Maternal age (years)b 26 (17–43) 25 (18–44) 0.9
Mother living with partnere 51 (89) 47 (98) 0.1
Characteristics at examination
Age (years)b 48 (41–52) 46 (41–51) 0.4
Height (cm)d 169.7 6 8.4 173.2 6 8.0 0.03
Weight (kg)d 77.7 6 18.3 79.0 6 13.9 0.7
BMI (kg/m2)b 25.9 (17.9–47.3) 25.5 (20.7–41.3) 0.5
Body surface area (m2)d 1.88 6 0.23 1.93 6 0.18 0.3
Percentage body fatd 30.9 6 8.99 28.0 6 9.37 0.1
Systolic blood pressure (mmHg)d 126 6 18 119 6 11 0.01
Diastolic blood pressure (mmHg)d 76 6 12 70 6 9 0.004
GFR (mL/min/1.73 m2)d
eGFR 98 6 11 99 6 10 0.8
mGFR 95 6 14 100 6 13 0.04
Urine albumin:creatinine ratio
(mg/mmol)b
0.4 (0–3.2) 0.4 (0–2.6) 0.8
Living with partnera 49 (86) 38 (79) 0.5
Completed higher educationa 29 (51) 19 (40) 0.3
Household income >800 000 NOKa,f 34 (60) 30 (62) 0.9
Regular smokera 13 (23) 6 (12) 0.2
Drinking alcohol at least weeklya 17 (30) 13 (27) 0.9
Physical exercise at least once a weeka 41 (73) 39 (81) 0.5
an (%), chi-squaredtest.
bMedian (minimum–maximum), t-test.
cz-score of BWGA, number of SD from mean.
dMean 6 SD, t-test.
en (%), Barnard’s test.
fEquivalent to 73 700 euros on 11 March 2020.
Table 2. Sex-stratified mGFR in various subgroups
Variables Females Males Interaction
Mean (95% CI) P-value Mean (95% CI) P-value P-value
BW
LBW 90.4 (86.3–94.5) 0.005 101.4 (95.5–107.4) 0.7 0.03
NBW 100.5 (94.9–106.1) 100.0 (95.5–104.4)
Zz-score
SGA 87.3 (81.2–93.3) 0.01 103.6 (95.2–111.9) 0.4 0.02
Not SGA 97.5 (93.2–101.8) 99.9 (95.8–104.0)
GA
Preterm 91.8 (86.8–96.9) 0.3 101.9 (94.8–109.0) 0.6 0.3
Term 96.1 (91.0–101.1) 100.0 (95.8–104.2)
Maternal pre-eclampsia
Yes 97.8 (86.5–109.0) 0.6 99.9 (85.3–114.5) 0.9 0.7
No 94.3 (90.6–98.1) 100.8 (97.0–104.6)
For each variable, the sex-stratified means of mGFR (95% CI of the mean) for the two subgroups are shown as mL/min/1.73 m2. The difference of the mean of the two subgroups was
tested using a t-test and the P-values are shown. In the total sample, the interaction between the main variables and sex was estimated using a linear regression model and the P-value
of the interaction is given.
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significant differences for men. In Table 2, sex-stratified mGFR
differences are shown. For women, both BW groups and
BWGA gave significant results. We further tested the effects us-
ing regression statistics demonstrating a significant interaction
with sex, therefore subsequent analyses were sex stratified.
Figure 2 shows the distribution of mGFR for men and women
in the two groups.
Associations were further tested using linear regression statis-
tics with mGFR as the dependent variable. For women, having
LBW was associated with 10.1 mL/min/1.73 m2 lower mGFR
(P¼ 0.005; see Table 3). When adjusting for age at examination,
maternal age and maternal civil status, the difference was 7.7 mL/
min/1.73 m2 (P¼ 0.03). For men, no significant associations
were seen. Similarly, a 1 kg higher BW was associated with a
6.0 mL/min/1.73 m2 higher mGFR for women (P¼ 0.002) but
no significant difference for men. For z-score, a 1 unit higher z-
score (defined as 1 SD higher BWGA in the MBRN) associated






























Mean = 101.4 Mean = 100
p=0.7
FIGURE 2: mGFR by BW group and sex. LBW, BW2300 g; NBW, BW 3500–4000 g.
Table 3. Multivariate regression analysis with GFR as a dependent variable: sex-stratified results
Variables Women Men
b (95% CI) P-value b (95% CI) P-value
LBW
Unadjusted 10.1 (17.1 to 3.2) 0.005 1.5 (6.1 to 9.1) 0.7
Adjusted 7.7 (14.5 to 0.8) 0.03 2.8 (5.2 to 10.7) 0.5
BW per 1 kg
Unadjusted 6.0 (2.4 to 9.6) 0.002 0.6 (4.8 to 3.6) 0.8
Adjusted 4.5 (0.8 to 8.1) 0.02 1.2 (5.6 to 3.2) 0.6
z-score per 1 Ua
Unadjusted 3.5 (1.0 to 6.0) 0.007 0.1 (3.1 to 3.0) 0.9
Adjusted 2.6 (0.1 to 5.1) 0.04 0.1 (3.3 to 3.1) 0.9
GA
Unadjusted 0.8 (0.2 to 1.8) 0.1 0.0 (1.0 to 0.9) 0.9
Adjusted 0.5 (0.5 to 1.4) 0.3 0.2 (1.2 to 0.8) 0.7
Maternal pre-eclampsia
Unadjusted 3.4 (17.8 to 11.0) 0.6 0.9 (11.5 to 13.2) 0.9
Adjusted 3.9 (17.2 to 9.4) 0.6 1.3 (11.2 to 13.8) 0.8
Adjustment for possible confounders: age at examination, maternal age and maternal civil status.
aSex specific z-score of BWGA, 1 U equals 1 SD.
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no difference was found for the men. Figure 3 shows these associ-
ations graphically for BW and BWGA (z-score).
We defined normal mGFR as >90 mL/min/1.73 m2 and us-
ing logistic regression statistics we analysed the odds ratio (OR)
for having mGFR<90 mL/min/1.73 m2. This in accordance
with the GFR cut-off used in chronic kidney disease (CKD) def-
initions [25] (no participants had GFR<60 mL/min/1.73 m2).
In women, LBW was associated with an unadjusted OR of 4.8
(95% CI 1.5–16; P¼ 0.01) for having a GFR<90 mL/min/
1.73 m2 (Table 4). In men, the corresponding unadjusted OR
was 1.4 (95% CI 0.3–6.0; P¼ 0.7). Adjusted analyses showed
similar results.
D I S C U S S I O N
This study is, to our knowledge, the first study to investigate
whether external marker–based mGFR associates with BW in
middle-aged mainly healthy adults. The study shows that
mainly healthy women with LBW have lower mGFR than
women with NBW and also that these associations are signifi-
cant for BWGA. Surprisingly, no significant associations were
found for men. The study sample comprised a fairly healthy
population without diabetes or the use of antihypertensive
medication, and the NBW group had lower blood pressure and
similar or lower BMI than the age-adjusted general population
[26, 27].
The findings of lower mGFR for women with LBW are in ac-
cordance with other studies showing associations between BW
and kidney function [14, 28]. Two previous studies have used
mGFR to study the association between BW and kidney func-
tion: Berglund et al. [18] studied previous kidney donors. They
found that higher BW reduced the risk of albuminuria, while
there was no association between BW and risk of
mGFR<60 mL/min/1.73 m2. However, only 15 of 216 partici-
pants had a BW <2500 g, and it should be remembered that
these participants had undergone nephrectomy, an operation
that leads to greater changes in GFR than would be expected for
BW. Gielen et al. [19] studied twins using creatinine clearance
and found that a 1 kg higher BW was associated with a 6 mL/
min higher creatinine clearance. In a meta-analysis by Das et al.
[28], the effect on GFR of 1 kg higher BW was found to be




























1 2 3 4
Birth weight (kg)
B
–4 –2 0 4
Birth weight for gestational age (z-score)
FIGURE 3: mGFR by BW and z-score. LBW, BW2300 g; NBW, BW 3500–4000 g.
Table 4. Logistic regression model for low GFR
Variables Women Men
b (95% CI) P-value b (95% CI) P-value
LBW
Unadjusted 4.8 ( 1.5–15.9) 0.01 1.4 (0.3–6.0) 0.7
Adjusted 3.8 ( 1.1–13.5) 0.04 1.1 (0.2–5.8) 0.9
BW (kg)
Unadjusted 0.4 (0.2–0.8) 0.008 0.9 (0.4–2.0) 0.8
Adjusted 0.5 (0.2–0.9) 0.03 1.0 (0.4–2.5) 1
z-score
Unadjusted 0.5 (0.3–0.8) 0.007 0.9 (0.5–1.5) 0.6
Adjusted 0.5 (0.3–0.9) 0.01 0.7 (0.3–1.6) 0.5
GA
Unadjusted 0.9 (0.8–1.0) 0.2 1.0 (0.8–1.2) 0.9
Adjusted 0.9 (0.8–1.1) 0.5 1.0 (0.8–1.3) 0.7
Maternal pre-eclampsia
Unadjusted 0.7 (0.1–5.3) 0.7 0.3 (0.0–2.1) 0.2
Adjusted 0.8 (0.1–6.5) 0.8 0.3 (0.0–3.8) 0.4
Sex-stratified analysis showing OR (95% CI) for GFR<90 mL/min/1.73 m2.
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studies of all age groups and several studies on children. In our
study, the overall effect on GFR per 1 kg higher BW was
3.45 mL/min/1.73 m2. For women, the effect was 4.5 mL/min/
1.73 m2 after adjustments for age at examination, maternal age
and civil status. The analysis of association between BWGA and
mGFR yielded a similar significant association for women, but
not for men. In a Swedish registry study, GA was found to be
associated with the risk of CKD [29]. However, this effect was
attenuated in older age, which could explain why we did not
find the same association, as the most diseased people are al-
ready excluded.
Most previous studies suggest a stronger effect of BW on
kidney disease and eGFR in men than in women [9–11, 17, 30].
We also showed a significant sex difference. However, in our
study the association between BW and GFR was only present in
women. This could have several explanations. First, in contrast
to other studies, we used external marker–based mGFR instead
of eGFR or creatinine clearance, giving GFR values not biased
by muscle mass etc., better representing the true GFR. Second,
we excluded patients with diabetes, treatment for hypertension
and/or eGFR<50 mL/min/1.73 m2 and have therefore probably
excluded those with the strongest association between BW and
low GFR. If LBW associates with kidney function mainly indi-
rectly via increased risk of traditional risk factors such as hyper-
tension, diabetes and metabolic syndrome [31], then the effect
of this could be even more important and there could be signifi-
cant sex differences. Third, there could be sex differences in the
mechanisms of kidney adaption and early kidney damage to be-
ing born with a small number of nephrons. As global GFR is
the sum of the filtration in all nephrons, it is difficult to distin-
guish normal filtration in a normal number of nephrons from
that of hyperfiltration in a reduced number of nephrons. It can
be speculated that a sex difference in age-related hyperfiltration
and adaption to nephron loss may exist, as suggested by other
researchers [15, 32, 33]. More studies are needed to explore the
natural course of GFR changes in adult age and whether this is
affected by BW. Such studies should probably include a cross
section of the total population, both healthy and unhealthy per-
sons, and also including ages>50 years.
The strength of this study is that a compulsory national reg-
istry was used for extraction of data on BW and other perinatal
variables. The Norwegian population registry allowed for the
detection of all eligible participants with the given characteris-
tics living in our local area and we could thus include subjects
within a certain age group that were the result of a singleton
birth. The use of mGFR rather than eGFR is a novelty in BW-
related GFR research, improving the validity of our results. In
fact, eGFR would not be sufficient to show the difference be-
tween the two BW groups in our material. Compared with gen-
eral population data, we observed that our study group with
NBW seemed to have lower blood pressure and BMI and thus
seemed to comprise a very healthy group of subjects. By study-
ing a fairly healthy population, our results reflect the association
between BW and kidney function, independent of several other
possible confounders. On the other hand, we have probably
also excluded patients who had low GFR mainly due to LBW.
In addition, the most severe LBW patients who might have
severe CKD may die at an early age. The main limitation is the
low final participation rate of the individuals includable in the
study. In the original power calculation we estimated the need
for 48 persons in each group. This was fulfilled in the total sam-
ple (57 LBW and 48 NBW). However, with the need for sex-
stratified analysis, the groups are smaller. Especially for the
men, where the differences were smaller, this study may have
been underpowered. The project was time consuming for the
participants and this may have caused selection bias. The study
only included Norwegians and may not reflect associations in
other populations.
In conclusion, our study shows that mGFR in mainly healthy
women 40–50 years of age is associated with BW. The associa-
tion, which was only demonstrated in women, could be
explained by underlying sex-specific mechanisms that should
be investigated further.
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